Galderma - PharmaKB

Galderma

Galderma S.A. is a Swiss pharmaceutical company specializing in dermatological treatments and skin care products. Formerly a subsidiary of L'Oréal and Nestlé, it has been held by a consortium of private institutional investors since 2019.

Trade Name	Drug Name	Approved	Patent Expires	Indication
Aklief	Trifarotene	2019-10-04	2025-2033	Acne vulgaris
Capex	Fluocinolone	1990-08-27	2027-2030	Psoriasis , Atopic dermatitis , Pruritus , Inflammation , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Acne vulgaris , Promyelocytic leukemia acute , Hyperpigmentation , Bacterial infections , Bacterial skin diseases , Escherichia coli infections , Hepatic encephalopathy , Neutropenia , Prostatitis , Fever , Urinary tract infections , Sinusitis , Typhoid fever , Diarrhea , Gonorrhea , Intraabdominal infections , Pseudomonas infections , Osteomyelitis , Campylobacter infections , Bacterial conjunctivitis , Staphylococcal infections , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Klebsiella infections , Otitis externa , Haemophilus infections , Protozoan infections , Cystitis , Dysentery , Bacteroides infections
Clobex	Clobetasol	2003-07-24	2025-2035	Inflammation , Dermatitis , Facial dermatoses , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses
Desowen	Desonide	1988-06-15	2025-2027	Inflammation, Facial dermatoses, Foot dermatoses, Hand dermatoses, Scalp dermatoses, Leg dermatoses
Differin	Adapalene	1996-05-31	2024-2040	Acne vulgaris, Rosacea, Toxoplasmosis, Bacterial infections, Streptococcal infections, Bacterial vaginosis, Pneumocystis pneumonia, Staphylococcal infections, Actinomycetales infections, Bacteroides infections
Epiduo	Adapalene, Benzoyl peroxide	2008-12-08	2024-2040	Acne vulgaris, Rosacea, Toxoplasmosis, Bacterial infections, Streptococcal infections, Bacterial vaginosis, Pneumocystis pneumonia, Staphylococcal infections, Actinomycetales infections, Bacteroides infections